Variable | Statistics |
---|---|
Median age at diagnosis, years (IQR) | 56 (49–63) |
Ethnicity, n (%) | |
 Chinese | 99 (79) |
 Non-chinese | 26 (21) |
Histology, n (%) | |
 Ductal | 110 (88) |
 Lobular | 8 (6) |
 Other | 7 (6) |
TNM stage, n (%) | |
 I | 20 (16) |
 II | 69 (55) |
 III | 35 (28) |
 IV | 1 (1) |
ER status, n (%) | |
 Positive | 83 (66) |
 Negative | 42 (34) |
PR status, n (%) | |
 Positive | 74 (59) |
 Negative | 51 (41) |
HER2 status, n (%) | |
 Positive | 55 (44)a |
 Negative | 70 (56) |
Genome-wide methylation, median (IQR) | 0.655 (0.650–0.660) |
Immune cell content (LUMP), median (IQR) | 0.989 (0.988–0.990) |
Cell type (proportion), median (IQR) | |
 CD19+ B-cell | 0.004 (0.000–0.027) |
 Natural killer cell | 0.012 (0.000–0.036) |
 CD4+ T cells | 0.000 (0.000–0.035) |
 CD8+ T cells | 0.090 (0.064–0.122) |
 Monocytes | 0.061 (0.038–0.078) |
 Granulocytes | 0.796 (0.690–0.860) |